These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16438868

  • 1. [Multivariate analysis of prognosis in gastrointestinal stromal tumor].
    Bai YK, Shao YF, Shi SS, Gao YN, Sun YT, Cheng SJ, Liu XY.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):598-601. PubMed ID: 16438868
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
    Bai YK, Shao YF, Cao WL, Shi SS, Yu LW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Analysis of prognostic factors in gastrointestinal stromal tumors of the small intestine].
    Bai YK, Shao YF, Shi SS, Gao YN, Sun YT, Wan YL.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):213-6. PubMed ID: 16167230
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B, Sökmensüer C.
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.
    Cancer; 2008 Feb 01; 112(3):608-15. PubMed ID: 18076015
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y, Cao H, Wang M, Shen DP, Shen ZY, Ni XZ, Wu ZY, Shen YY, Liu Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar 01; 12(2):150-4. PubMed ID: 19296250
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep 01; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic factors in gastrointestinal stromal tumors among a group of Mexican patients].
    Medina-Franco H, Aguilar-Jiménez JR, Medina-Cuairán JZ.
    Gac Med Mex; 2009 Sep 01; 145(2):91-6. PubMed ID: 19518014
    [Abstract] [Full Text] [Related]

  • 12. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK.
    Cancer; 2006 Nov 01; 107(9):2237-44. PubMed ID: 16998931
    [Abstract] [Full Text] [Related]

  • 13. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.
    Med Sci Monit; 2007 Nov 01; 13(11):CR515-522. PubMed ID: 17968300
    [Abstract] [Full Text] [Related]

  • 14. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
    Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U, Kakol M, Osuch C, Polkowski M, Głuszek S, Zurawski Z, Ruka W.
    Ann Surg Oncol; 2007 Jul 01; 14(7):2018-27. PubMed ID: 17473953
    [Abstract] [Full Text] [Related]

  • 15. Prognostic assessment of gastrointestinal stromal tumor.
    Yan H, Marchettini P, Acherman YI, Gething SA, Brun E, Sugarbaker PH.
    Am J Clin Oncol; 2003 Jun 01; 26(3):221-8. PubMed ID: 12796588
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
    Fontana MG, Rossi E, Bassotti G, Aquilano MC, Cadei M, Grigolato P, Villanacci V.
    J Gastroenterol Hepatol; 2007 Nov 01; 22(11):1754-9. PubMed ID: 17914946
    [Abstract] [Full Text] [Related]

  • 17. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
    Tsai MC, Lin JW, Lin SE, Chen HH, Lee CM, Hu TH.
    Dis Colon Rectum; 2008 Oct 01; 51(10):1535-43. PubMed ID: 18633679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
    Alvarado-Cabrero I, Vázquez G, Sierra Santiesteban FI, Hernández-Hernández DM, Pompa AZ.
    Ann Diagn Pathol; 2007 Feb 01; 11(1):39-45. PubMed ID: 17240306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.